BioCentury | Jul 31, 2006
Analyst Picks & Changes

Analyst picks & changes

...MM drug Thalomid to $343.9M from $328M and to $434M from $425.2M, respectively. CeNeS (LSE:CEN) First Berlin...
Items per page:
1 - 1 of 1
BioCentury | Jul 31, 2006
Analyst Picks & Changes

Analyst picks & changes

...MM drug Thalomid to $343.9M from $328M and to $434M from $425.2M, respectively. CeNeS (LSE:CEN) First Berlin...
Items per page:
1 - 1 of 1